CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionP/E ratio is 332×, higher than 95% of its Medical Instruments & Supplies peers (median 30.34×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
0.21%
Annual Rate
CNY 0.08Paid semi-annual
Payout Ratio
250.0%High
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.06BCNY602.78M · vs all stocks (USD)
Trailing P/E
332.00xvs Medical Instruments & Supplies peers
Revenue (TTM)
425.33MCNY63.17M · vs all stocks (USD)
Profit Margin
2.60%vs Medical Instruments & Supplies peers
Beta
0.8290xvs all stocks
52-Week Change
61.81%vs all stocks
Forward Annual Dividend Yield
0.21%vs all stocks
Market Capitalization
4.06BCNY602.78M · vs all stocks (USD)
Enterprise Value
3.45BCNY512.95M · vs all stocks (USD)
Trailing P/E
332.00xvs Medical Instruments & Supplies peers
Forward P/E
43.80xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
9.54xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.19xvs Medical Instruments & Supplies peers
Enterprise to Revenue
8.12xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
58.66xvs Medical Instruments & Supplies peers
Gross Margin
26.80%vs Medical Instruments & Supplies peers
Profit Margin
2.60%vs Medical Instruments & Supplies peers
Operating Margin
8.45%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
0.14%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
0.36%vs Medical Instruments & Supplies peers
Revenue (TTM)
425.33MCNY63.17M · vs all stocks (USD)
Revenue per Share (TTM)
3.86CNYUpdated Aug 20, 2026Quarterly Revenue Growth
94.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
92.05MCNY13.67M · vs all stocks (USD)
EBITDA (TTM)
24.52MCNY3.64M · vs all stocks (USD)
Net Income (TTM)
11.05MCNY1.64M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
70.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
14.25MCNY2.12M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-70.30MCNY-10.44M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0800CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
0.21%vs all stocks
Trailing Annual Dividend Rate
0.2900CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.74%vs all stocks
Payout Ratio
250.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
4.98MCNYFY2025 · Dec 31, 2025Revenue
356.69MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
276.93MCNYFY2025 · Dec 31, 2025Gross Profit
79.76MCNYFY2025 · Dec 31, 2025Operating Income
3.22MCNY477.89K · vs all stocks (USD)
Pre-tax Income
1.34MCNYFY2025 · Dec 31, 2025Income Tax Expense
-1.22MCNYFY2025 · Dec 31, 2025Net Income
2.55MCNYFY2025 · Dec 31, 2025EBIT
1.80MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
70.72MCNYFY2025 · Dec 31, 2025Research & Development
21.96MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
19.25MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
463.50KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
112.41MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
112.41MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.55MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.07MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-61.44MCNYFY2025 · Dec 31, 2025Free Cash Flow
-152.61MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
371.03MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.55MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.57MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-34.13MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-32.44MCNYFY2025 · Dec 31, 2025Capital Expenditures
-91.17MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.52BCNYFY2025 · Dec 31, 2025Sale of Investments
2.66BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
51.53MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.56MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.06MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-29.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
122.25MSharesUpdated Aug 20, 2026Float Shares
41.36MSharesUpdated Aug 20, 2026% Held by Insiders
67.78%vs all stocks
% Held by Institutions
3.89%vs all stocks
Total Cash (MRQ)
780.23MCNY115.88M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.38CNYUpdated Aug 20, 2026Total Debt (MRQ)
164.70MCNY24.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0884xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
3.28xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
15.15CNYUpdated Aug 20, 2026Total Assets
2.01BCNY297.92M · vs all stocks (USD)
Total Current Assets
1.02BCNYFY2025 · Dec 31, 2025Total Liabilities
161.97MCNYFY2025 · Dec 31, 2025Total Non-current Assets
989.76MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
42.62MCNYFY2025 · Dec 31, 2025Total Current Liabilities
119.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
371.03MCNYFY2025 · Dec 31, 2025Other Short-term Investments
435.11MCNYFY2025 · Dec 31, 2025Accounts Receivable
90.26MCNYFY2025 · Dec 31, 2025Inventory
100.67MCNYFY2025 · Dec 31, 2025Accounts Payable
91.44MCNYFY2025 · Dec 31, 2025Short-term Debt
3.50MCNYFY2025 · Dec 31, 2025Other Current Liabilities
84.33KCNYFY2025 · Dec 31, 2025Long-term Debt
27.92MCNYFY2025 · Dec 31, 2025Common Stock (Book)
122.25MCNYFY2025 · Dec 31, 2025Retained Earnings
452.19MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.84BCNY273.87M · vs all stocks (USD)
52-Week Low
20.90CNYUpdated Aug 20, 202652-Week High
38.98CNYUpdated Aug 20, 202652-Week Change
61.81%vs all stocks
Beta
0.8290xvs all stocks
50-Day MA
29.08CNYUpdated Aug 20, 2026200-Day MA
29.61CNYUpdated Aug 20, 2026Avg 10-Day Volume
3.82MSharesUpdated Aug 20, 2026Avg 30-Day Volume
5.00MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1000CNYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 332×, higher than 95% of its Medical Instruments & Supplies peers (median 30.34×)Significant
P/E ratio: 332Industry median: 30.34Industry P95: 123.965Peers compared: 65.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.50Dividend per Share: 0.29Earnings per Share: 0.10
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Insteel Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Wellsun Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Keeper Technical Laboratory
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
HG Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jinlihua Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Rychen Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shenzhen Refond Optoelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Netgear Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Alltop Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Flower King Eco-Engineering Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Beijing Zhidemai Technology Co., Ltd.
2 interpretationsLow-Leverage Liquidity ConfigurationMinimal Tax and Interest Drag
Samg Entertainment Co., Ltd.
2 interpretationsLow-Leverage Liquidity ConfigurationMinimal Tax and Interest Drag
Escorts Kubota Ltd.
2 interpretationsLow-Leverage Liquidity ConfigurationMinimal Tax and Interest Drag